Trials / Completed
CompletedNCT01457755
Gilead Sustained Virologic Response (SVR) Registry
A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects With Chronic Hepatitis C Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,625 (actual)
- Sponsor
- Gilead Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This Registry is designed to provide long term clinical and virologic follow up in participants who have achieved sustained virologic response (SVR) while participating in a previous Gilead sponsored hepatitis C virus (HCV) study. This long term follow up study is observational and no treatment is provided for HCV.
Conditions
Timeline
- Start date
- 2012-04-13
- Primary completion
- 2017-03-28
- Completion
- 2018-01-08
- First posted
- 2011-10-24
- Last updated
- 2018-08-31
Locations
325 sites across 17 countries: United States, Australia, Austria, Belgium, Canada, Czechia, Estonia, France, Germany, Italy, Netherlands, New Zealand, Poland, Puerto Rico, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01457755. Inclusion in this directory is not an endorsement.